尿毒症毒素与心血管疾病：研究与临床结局研究 - Suppr

Suppr

超能文献

Uraemic toxins and cardiovascular disease: research versus clinical outcome studies.

作者信息

Vanholder Raymond, Laecke Steven Van, Verbeke Francis, Glorieux Griet, Biesen Wim Van

机构信息

Nephrology Section, University Hospital, Ghent, Belgium.

出版信息

NDT Plus. 2008 Feb;1(1):2-10. doi: 10.1093/ndtplus/sfm024. Epub 2007 Dec 19.

DOI:10.1093/ndtplus/sfm024

PMID:30792775

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375242/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab51/6375242/b3c0ae8f068a/sfm024fig1.jpg

相似文献

Uraemic toxins and cardiovascular disease: research versus clinical outcome studies.

NDT Plus. 2008 Feb;1(1):2-10. doi: 10.1093/ndtplus/sfm024. Epub 2007 Dec 19.

Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway.

J Physiol. 2015 Feb 1;593(3):601-18; discussion 618. doi: 10.1113/jphysiol.2014.283887. Epub 2014 Dec 18.

In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.

J Pharm Pharmacol. 2006 Nov;58(11):1467-74. doi: 10.1211/jpp.58.11.0007.

Genesis of the uraemic syndrome: role of uraemic toxins.

Wien Klin Wochenschr. 1998 Aug 21;110(15):511-20.

Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?

Clin Sci (Lond). 2016 Dec 1;130(23):2209-2216. doi: 10.1042/CS20160393.

Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.

Nephrol Dial Transplant. 2020 Feb 1;35(2):328-335. doi: 10.1093/ndt/gfz189.

From old uraemic toxins to new uraemic toxins: place of 'omics'.

Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii2-iii5. doi: 10.1093/ndt/gfy212.

Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.

Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.

Nephrol Dial Transplant. 2018 Jun 1;33(6):978-986. doi: 10.1093/ndt/gfx224.

Removal of protein-bound uraemic toxins by haemodialysis.

Blood Purif. 2013;35 Suppl 2:20-5. doi: 10.1159/000350843. Epub 2013 May 3.

引用本文的文献

In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells.

J Clin Med. 2022 Sep 10;11(18):5329. doi: 10.3390/jcm11185329.

High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cells.

Sci Rep. 2021 Jan 13;11(1):1144. doi: 10.1038/s41598-020-80016-7.

Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.

BMC Nephrol. 2019 Dec 31;21(1):2. doi: 10.1186/s12882-019-1669-3.

The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1.

Kidney Dis (Basel). 2018 Feb;4(1):20-28. doi: 10.1159/000484603. Epub 2017 Nov 17.

The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment.

J Diabetes Metab Disord. 2015 Apr 23;14:34. doi: 10.1186/s40200-015-0162-1. eCollection 2015.

本文引用的文献

Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.

Nephrol Dial Transplant. 2007 Dec;22(12):3381-90. doi: 10.1093/ndt/gfm210. Epub 2007 Aug 27.

Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes.

Am J Kidney Dis. 2007 Aug;50(2):279-88. doi: 10.1053/j.ajkd.2007.05.009.

Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy.

Nephron Clin Pract. 2007;107(1):c1-6. doi: 10.1159/000105137. Epub 2007 Jul 5.

EBPG guideline on dialysis strategies.

Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii5-21. doi: 10.1093/ndt/gfm022.

The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells.

J Thromb Haemost. 2007 Jun;5(6):1302-8. doi: 10.1111/j.1538-7836.2007.02540.x.

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Clin Chim Acta. 2007 Apr;379(1-2):87-94. doi: 10.1016/j.cca.2006.12.026. Epub 2007 Jan 16.

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.

Am J Kidney Dis. 2007 Feb;49(2):267-75. doi: 10.1053/j.ajkd.2006.11.026.

The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.

Eur Heart J. 2007 Feb;28(4):478-83. doi: 10.1093/eurheartj/ehl455. Epub 2007 Jan 12.

Mass-spectrometric identification of a novel angiotensin peptide in human plasma.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):297-302. doi: 10.1161/01.ATV.0000253889.09765.5f. Epub 2006 Nov 30.

P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

Nephrol Dial Transplant. 2007 Feb;22(2):592-6. doi: 10.1093/ndt/gfl584. Epub 2006 Oct 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验